Volume | 154,219 |
|
|||||
News | - | ||||||
Day High | 1.38 | Low High |
|||||
Day Low | 1.27 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.27 | 1.27 | 1.38 | 1.34 | 1.26 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
671 | 154,219 | US$ 1.31 | US$ 202,723 | - | 0.650101 - 2.12 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:56:07 | 6 | US$ 1.3099 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
99.38M | 74.72M | - | 8.23M | -32.49M | -0.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Clearside Biomedical News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.33 | 1.48 | 1.25 | 1.35 | 218,785 | -0.02 | -1.50% |
1 Month | 1.52 | 1.61 | 1.10 | 1.33 | 280,627 | -0.21 | -13.82% |
3 Months | 1.34 | 2.12 | 1.10 | 1.55 | 387,955 | -0.03 | -2.24% |
6 Months | 0.73 | 2.12 | 0.650101 | 1.39 | 285,374 | 0.58 | 79.45% |
1 Year | 1.06 | 2.12 | 0.650101 | 1.30 | 198,636 | 0.25 | 23.58% |
3 Years | 2.97 | 7.73 | 0.650101 | 3.42 | 558,886 | -1.66 | -55.89% |
5 Years | 1.23 | 7.73 | 0.56 | 2.84 | 584,322 | 0.08 | 6.50% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |